ASPIS Open Symposium during ESTIV Congress 24-25 November 2022

ASPIS Open Symposium during ESTIV Congress 24-25 November 2022

The ASPIS Open Symposium will happen during the 21st European Society of Toxicology In Vitro (ESTIV) Congress on 24-25 November 2022 in Sitges, Barcelona (Spain), a bi-annual appointment aiming to create a forum of scientists in a unique atmosphere for discussions and knowledge exchange focusing on the development of in vitro and in silico approaches.

During this event, the ASPIS cluster will present the work performed by the three Horizon 2020 projects composing the consortia (ONTOX, PrecisionTOX, and RISKHUNT3R). The objectives of the ASPIS Open Symposium will include: 

  • Increasing confidence in and promoting NAM regulatory uptake; 
  • Delineating foreseen ASPIS impact on regulatory issues; 
  • Engaging young researchers and supporting scientific networking; 
  • Facilitating interactions among ASPIS and international stakeholders

To consult the tentative agenda, please click here. Registration are already open! You can access the registration page by clicking on the following button.

 

KICK-OFF MEETING OF THE ASPIS CLUSTER

KICK-OFF MEETING OF THE ASPIS CLUSTER

On the 3rd and 4th of November 2021, the Final Symposium of the EU-ToxRisk project was held in Brussels, Belgium, and online. The purpose of this event was for the EU-ToxRisk consortium partners to present their results, and to discuss the different strategies and methods developed within the project with external stakeholders.  

This meeting was a way for the EU-ToxRisk project to pass the torch to the RISK HUNT3R consortium. and to formally introduce, the ASPIS cluster, which is a collaboration of the H2020 funded projects ONTOXPrecisionTOX and RISK-HUNT3R 

During the ASPIS Kick-off meeting, which constituted the fourth part of the event, each project was presented as well as the purpose and planned implementation of the ASPIS Cluster. It was an opportunity for cluster members to meet each other in person and to exchange about how the projects can collaborate together.  

 

General Assembly Meeting, 4-8 July 2022

General Assembly Meeting, 4-8 July 2022

From 4 to 8 July 2022, the General Assembly Meeting of RISK-HUNT3R took place in Egmond aan Zee, the Netherlands.

This event was an opportunity for the project members to discuss together progress and challenges towards NGRA, during the general assembly and parallel sessions.

Young researchers presented their work through posters and short oral presentations and took part in different training sessions and workshops organised in connection with the consortium meeting.

The video below presents pictures taken during the event. Check it out to know more about the meeting.

Mini Symposium – Orienteering for regulatory needs, 14 March 2022

Mini Symposium – Orienteering for regulatory needs, 14 March 2022

On 14 March 2022,  the RISK-HUNT3R consortium held a short Mini Symposium titled “Orienteering for regulatory needs”. During this event, the project consortium had the opportunity to beneficiate from a summary of all the progress made so far in the project.

It was also an opportunity to listen to all of the partners’ inputs and to share knowledge within the project.

To know more about the project, please find here the link to the agenda:

 

 

 

KICK-OFF MEETING OF THE RISK-HUNT3R PROJECT

KICK-OFF MEETING OF THE RISK-HUNT3R PROJECT

On the 12th and 13th of October 2021 happened the face-to-face Kick-off Meeting of the European project RISK-HUNT3R in Egmond an Zee, the Netherlands. This meeting was organised in connection with the Final General assembly of the EU-ToxRisk project, held on 11-12 October.  

RISK-HUNT3R being the continuation of the research made during the EU-ToxRisk project, it was an opportunity for all consortium members to finally meet in person, after a first online meeting in June. 

All partners had the occasion to introduce themselves, discuss the progress made so far in each work package, and to learn more about the results obtained by the EU-ToxRisk consortium.